Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | P2RY6 | Q15077 | 5/20 | 0.65 |
| ▸ | P2RY2 | P41231 | 18/20 | 0.59 |
| ▸ | P2RY4 | P51582 | 4/20 | 0.57 |
| ▸ | NT5E | P21589 | 1/20 | 0.56 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4952498 | 0.86 | P2RY6 (0.61) | P2RY6P2RY2P2RY4NT5E | |
| SCHEMBL18574264 | 0.86 | NT5E (0.67) | P2RY6P2RY2P2RY4NT5E | |
| SCHEMBL29185234 | 0.86 | NT5E (0.67) | P2RY6P2RY2P2RY4NT5E | |
| SCHEMBL14946397 | 0.86 | NT5E (0.67) | P2RY6P2RY2P2RY4NT5E | |
| SCHEMBL14929505 | 0.86 | NT5E (0.67) | P2RY6P2RY2P2RY4NT5E | |
| SCHEMBL19998473 | 0.85 | P2RY6 (0.62) | P2RY6P2RY2P2RY4NT5E | |
| SCHEMBL20003786 | 0.85 | P2RY6 (0.62) | P2RY6P2RY2P2RY4NT5E | |
| SCHEMBL19998458 | 0.85 | P2RY6 (0.71) | P2RY6P2RY2P2RY4NT5E | |
| SCHEMBL20003868 | 0.85 | P2RY6 (0.71) | P2RY6P2RY2P2RY4NT5E | |
| SCHEMBL19998476 | 0.84 | P2RY6 (0.65) | P2RY6P2RY2P2RY4NT5E |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20100068179-A1 | Phosphohalohydrins, Process For The Production Thereof And Use Thereof | INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE (FR) | 2010-03-18 | — | — | US | disclosed |
| US-7625879-B2 | Phosphohalohydrins, process for the production thereof and use thereof | INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE (FR) | 2009-12-01 | — | — | US | disclosed |
| US-7432253-B2 | Phosphoepoxides, method for making same and uses | INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE (FR) | 2008-10-07 | — | — | US | disclosed |
| US-20060287274-A1 | Phosphoepoxides, method for making same and uses | INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE (FR) | 2006-12-21 | — | — | US | disclosed |
| US-20060287281-A1 | Phosphohalohydrins, process for the production thereof and use thereof | INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE (FR) | 2006-12-21 | — | — | US | disclosed |
| US-7109183-B2 | Phosphohalohydrins, process for the production thereof and use thereof | Institut National de la Sante et de la Recherchik Medicale (FR) | 2006-09-19 | — | — | US | disclosed |
| US-7101711-B1 | Phosphoepoxides, method for making same and uses | INSTITUT NATIONAL DE LA SANTA ET DE LA RECHERCHE MEDICALE (FR) | 2006-09-05 | — | — | US | disclosed |
| US-20040087555-A1 | Phosphohalohydrins, process for the production thereof and use thereof | INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICATE (FR) | 2004-05-06 | — | — | US | disclosed |
| US-6660723-B1 | Activating primate gamma delta lymphocytes | INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE (FR) | 2003-12-09 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20060287274-A1 | Phosphoepoxides, method for making same and uses | CD4, CCR9, BCL9 | P2RY6 302/4885P2RY2 169/4885P2RY4 211/4885 |
| US-20040087555-A1 | Phosphohalohydrins, process for the production thereof and use thereof | CD4, HRH3, HRH1 | P2RY6 3011/4885P2RY2 2241/4885P2RY4 2886/4885 |
| US-20060287281-A1 | Phosphohalohydrins, process for the production thereof and use thereof | CD4, CCR9, BCL9 | P2RY6 1314/4885P2RY2 975/4885P2RY4 784/4885 |
| US-20100068179-A1 | Phosphohalohydrins, Process For The Production Thereof And Use Thereof | CD4, CCR9, ICOS | P2RY6 845/4885P2RY2 805/4885P2RY4 834/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.